Tadeusz Wojciech Lapinski

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. ncbi Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical University of Bialystok, 15 540 Bialystok, Zurawia str, 14, Poland
    World J Gastroenterol 10:3650-3. 2004
  2. ncbi SNP RS12979860 related spontaneous clearance of hepatitis c virus infection in HCV/HIV-1 coinfected patients
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases and Hepatology, Medical University of Bialystok
    Przegl Epidemiol 67:407-9, 517-9. 2013
  3. doi HBV mutations and their clinical significance
    T W Lapinski
    Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Poland
    Adv Med Sci 57:18-22. 2012
  4. ncbi [HBV infection and pregnancy]
    Tadeusz Wojciech Łapiński
    Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 64:503-7. 2010
  5. ncbi [Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland]
    Tadeusz Wojciech Łapiński
    Klinika Chorób Zakaźnych i Hepatologii, Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 63:501-4. 2009
  6. ncbi [Prevalence, clinical and therapeutical implications of active CMV infection in patients with chronic hepatitis C]
    Tadeusz Wojciech Lapinski
    Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 63:305-9. 2009
  7. doi Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland
    Liver Int 29:1158-61. 2009
  8. ncbi [Influence of cryoglobulinaemia on renal function in patients with chronic HCV infection]
    Tadeusz Wojciech Lapinski
    Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 63:103-6. 2009
  9. ncbi [Endocrinal dysfunctions in liver failure of different etiologies and during interferon therapy in patients with chronic hepatitis B and C]
    Tadeusz Wojciech Lapinski
    Medical University of Białystok, Department of Infectious Diseases, Poland
    Pol Merkur Lekarski 24:468-71. 2008
  10. ncbi [Activity of cytokines in chronic HCV-infected patients]
    Tadeusz Wojciech Lapinski
    Wojewódzki Szpital Specjalistyczny im K Dłuskiego w Białymstoku
    Przegl Epidemiol 61:747-54. 2007

Collaborators

Detail Information

Publications21

  1. ncbi Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical University of Bialystok, 15 540 Bialystok, Zurawia str, 14, Poland
    World J Gastroenterol 10:3650-3. 2004
    ..Activity of apoptosis was evaluated by serum sFas/sFasL concentration measurement. Moreover dependence between apoptosis and HBV-DNA or HCV-RNA levels was studied...
  2. ncbi SNP RS12979860 related spontaneous clearance of hepatitis c virus infection in HCV/HIV-1 coinfected patients
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases and Hepatology, Medical University of Bialystok
    Przegl Epidemiol 67:407-9, 517-9. 2013
    ..The aim of this analysis was evaluation of impact of rs12979860 polymorphism on HIV or HCV viral load, CD3, CD4 and CD8 count as well as HCV clearance among HCV/HIV coinfected patients...
  3. doi HBV mutations and their clinical significance
    T W Lapinski
    Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Poland
    Adv Med Sci 57:18-22. 2012
    ....
  4. ncbi [HBV infection and pregnancy]
    Tadeusz Wojciech Łapiński
    Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 64:503-7. 2010
    ..Women with low viral load and slight liver damage, can be treated after birth, but appropriate newborn prophylaxis against HBV infection should be provided immediately...
  5. ncbi [Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland]
    Tadeusz Wojciech Łapiński
    Klinika Chorób Zakaźnych i Hepatologii, Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 63:501-4. 2009
    ..The aim was assessment of the incidence of genotype 4 HCV infection in north-eastern Poland, that included also epidemiological and clinical analysis...
  6. ncbi [Prevalence, clinical and therapeutical implications of active CMV infection in patients with chronic hepatitis C]
    Tadeusz Wojciech Lapinski
    Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 63:305-9. 2009
    ..Coinfection with CMV has not influence on the laboratory biochemical parameters and injury of liver tissue. Moreover, it does not affect the efficacy of anti-HCV treatment...
  7. doi Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland
    Liver Int 29:1158-61. 2009
    ..The presence of cryoglobulins was investigated in the sera of HCV-monoinfected and HCV/HIV-coinfected individuals. Associations between types of cryoglobulins and HCV genotypes, viral load and renal function tests were also evaluated...
  8. ncbi [Influence of cryoglobulinaemia on renal function in patients with chronic HCV infection]
    Tadeusz Wojciech Lapinski
    Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Białymstoku
    Przegl Epidemiol 63:103-6. 2009
    ..Objective was investigating the existence of cryoglobulinaemia, its types and relation with renal impairment in patients chronically infected with hepatitis C virus...
  9. ncbi [Endocrinal dysfunctions in liver failure of different etiologies and during interferon therapy in patients with chronic hepatitis B and C]
    Tadeusz Wojciech Lapinski
    Medical University of Białystok, Department of Infectious Diseases, Poland
    Pol Merkur Lekarski 24:468-71. 2008
    ..Moreover, these incorrect metabolic pathways as well as oxygen deficiency in hepatocytes are implicated in the pathogenesis of endocrine system diseases. The different endocrinal dysfunctions make worse patient's prognosis...
  10. ncbi [Activity of cytokines in chronic HCV-infected patients]
    Tadeusz Wojciech Lapinski
    Wojewódzki Szpital Specjalistyczny im K Dłuskiego w Białymstoku
    Przegl Epidemiol 61:747-54. 2007
    ..Cognition of HCV influence on the regulation of nonspecific immunology response and apoptotic pathways could bring nearer the comprehension of chronic hepatitis C development and indicate new treatment's directions...
  11. ncbi Concentrations of ssDNA in liver tissue and its correlation with sFas and sFasL in serum of patients infected with HBV, HCV, HCV and HIV
    T W Łapinski
    Department of Infectious Diseases, Medical University of Białystok, Poland
    Adv Med Sci 52:109-13. 2007
    ....
  12. pmc Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical University of Bialystok, Zurawia str, 14, 15 540 Bialystok, Poland
    World J Gastroenterol 11:400-2. 2005
    ....
  13. ncbi [The peripheral polyneuropathy in patients with chronic HCV infection treated peginterferon alfa with ribavirin]
    Tadeusz Wojciech Lapinski
    Klinika Obserwacyjno Zakaźna Akademii Medycznej, Białymstoku
    Pol Merkur Lekarski 18:431-2. 2005
    ..It is qualified hard whether cause of peripheral polineuropathy: interferon's or pegylated part. The finished of antiviral treatments as well as use of steroids in therapy were reason of fast improvement of patients...
  14. ncbi Specific ssDNA concentration in liver tissue as an index of apoptosis in hepatitis C virus-infected patients
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical University of Bialystok, Bialystok 15 540, Zurawia str, 14, Poland
    World J Gastroenterol 11:6130-3. 2005
    ..To evaluate the activity of apoptosis in liver tissue and explore its possible association with hepatic necroinflammation and fibrosis as well as serum hepatitis C virus (HCV) load...
  15. ncbi Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical University of Bialystok, Bialystok, Poland
    Viral Immunol 19:570-5. 2006
    ..There was no correlation between sFas, sFasL, and HIV-1 viral load. On the other hand, sFas concentration and the presence of sFasL were related to CD4+ T lymphocyte count...
  16. ncbi The concentration of Fas in the serum and liver tissue in viral chronic hepatitis B patients treated with lamivudine
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical Academy of Bialystok, Poland
    Hepatogastroenterology 52:575-9. 2005
    ..The dependence of the Fas concentration in the liver tissue and serum was estimated in reference to the elimination of HBV-DNA, necroinflammatory changes and fibrotic activity in chronic hepatitis B patients treated with lamivudine...
  17. ncbi The concentration of sFasL, ICE and IL-1beta in the serum and the liver tissue of chronic HCV infected patients
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases, Medical Academy of Bialystok, Poland
    Hepatogastroenterology 52:1479-83. 2005
    ..In HCV infected patients HCV, apoptosis is as important as cytotoxicity. The aim of the present study was to estimate the activity of apoptosis in patients infected with hepatitis C before and during antiviral treatment...
  18. ncbi Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity
    Alicja Wiercinska-Drapalo
    Department of Infectious Diseases, Medical University of Bialystok, Zurawia 14, 15 540 Bialystok, Poland
    Regul Pept 140:1-4. 2007
    ....
  19. ncbi [Occurrence of autoantibodies in patients with alcoholic liver disease]
    Tomasz Szulzyk
    Medical University of Bialystok, Department of Infectious Diseases and Hepathology, Poland
    Pol Merkur Lekarski 33:143-6. 2012
    ..The aim of the study was to evaluate of occurrence of autoantibodies in patients with alcoholic liver disease...
  20. doi Influence of HCV and HIV on Development of Cryoglobulinemia
    Magdalena Rogalska-Płońska
    Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland
    Viral Immunol 28:145-52. 2015
    ..Effective antiretroviral therapy seems to be protective against cryoglobulinemia development in HIV mono-infected patients. ..
  21. ncbi [Predictive factors of virological response in chronically HCV infected]
    Tadeusz Wojciech Lapinski
    Department of Infectious Diseases and Hepathology, Medical University of Bialystok, Poland
    Pol Merkur Lekarski 33:159-62. 2012
    ..Very interesting seems to be also results of studies on association between vitamine D concentration and treatment efficacy. However in the future the most important predictive factor remain probably early on-treatment viral response...